Skip to content
10-Q/A

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-12-049770

← back to feed
Filed
Sep 6, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Aug 13, 2012 13.55M sh
Operating Cash Flow Q1 2012 · Jun 30, 2012 $505.98K
Operating Cash Flow Q1 2012 · Jun 30, 2011 −$708.81K
Stockholders Equity Q1 2012 · Jun 30, 2012 $18.11M
Stockholders Equity Q1 2012 · Mar 31, 2012 $18.34M
Current Liabilities Q1 2012 · Jun 30, 2012 $446.19K
Current Liabilities Q1 2012 · Mar 31, 2012 $1.5M
Current Assets Q1 2012 · Jun 30, 2012 $8.34M
Current Assets Q1 2012 · Mar 31, 2012 $9.14M
Total Assets Q1 2012 · Jun 30, 2012 $18.56M
Total Assets Q1 2012 · Mar 31, 2012 $19.84M
Sga Expense Q1 2012 · Jun 30, 2012 $503.59K
Sga Expense Q1 2012 · Jun 30, 2011 $217.02K
Net Income Q1 2012 · Jun 30, 2012 −$483.71K
Net Income Q1 2012 · Jun 30, 2011 $1.6M
Operating Income Q1 2012 · Jun 30, 2012 −$613.9K
Operating Income Q1 2012 · Jun 30, 2011 $2.19M
Gross Profit Q1 2012 · Jun 30, 2012 $0
Gross Profit Q1 2012 · Jun 30, 2011 $2.57M
Cost Of Revenue Q1 2012 · Jun 30, 2012 $0
Cost Of Revenue Q1 2012 · Jun 30, 2011 $3M